藥物成份

共有 21645 個藥物成份

9. 0.4 ML HIV-1/2 酵素結合物 (HIV-1/2 HRP-CONJUGATE): 1 瓶 HORSERADISH PEROXIDASE-CONJUGATED GOAT ANTI-HUMAN IGG ANTIBODIES, WITH 0.01% GENTAMICIN AND 0.05% 4-DIMETHYLAMINOANTIPYRINE. STORE AT 2~8°C.

• 關聯藥證數量: 1

9. Coverslips.

• 關聯藥證數量: 1

9.0.4 ML HTLV-I/II 酵素結合物 (HTLV-I/II HRP-CONJUGATE):1 瓶 HORSERADISH PERODIDASE-CONJUGATED GOAT ANTI-HUMAN IGG ANTIBODIES, WITH 0.01 % GENTAMICIN AND 0.05 % 4-DIMETHYLAMINOANTIPYRINE. STORE AT 2~8°C

• 關聯藥證數量: 1

9.0.4ML HIV-1/2 酵素結合物 (HIV-1/2 HRP-CONJUGATE):1瓶 HORSEADISH PEROXIDASE-CONJUGATED GOAT ANTI-HUMAN IGG ANTIBODIES, WITH 0.01% GENTAMICIN AND 0.05% 4-DIMETHYLAMINOANTIPYRINE. STORE AT 2-8°C.

• 關聯藥證數量: 1

9.ACA Sample Diluent, 1 vial - containing PBS-buffered saline, protein stabilizers and preservative.\n10.ACA PBS Concentrate, 1 vial of 20x concentrate - colored red containing PBS-buffered saline.\n11.HRP IgG Conjugate, (goat), anti-human IgG, 1 vial - colored blue containing buffer, protein stabilizers and preservative.\n12.TMB Chromogen, 1 vial containing stabilizers.\n13.HRP Stop Solution, 0.344M Sulfuric Acid.

• 關聯藥證數量: 1

9.BLOTTING POWDER:10 PACKETS (1G EACH)

• 關聯藥證數量: 1

9.Capture microplate:coated with anti-RNA:DNA hybrid antibodies.10.Detection Reagent 1:alkaline phosphatase-conjugated antibodies to RNA:DNA hybrid.11.Detection Reagent 2:CDP-Star with Emerald II (chemiluminescent substrate).12.Wash buffer concentrate:contains 1.5% sodium azide.

• 關聯藥證數量: 1

9.HRP Sample Diluent, containing Tris-buffered saline, Tween 20, protein stabilizers10. HRP Wash Concentrate, 1vial of 40x concentrate containing Tris-buffered saline and Tween20\n11.HRP IgG Conjugate,(goat), anti-human, containing buffer, protein stabilizers\n12.TMB Chromogen, 1 vial containing stabilizers\n13.HRP Stop Solution：0.344M Sulfuric Acid

• 關聯藥證數量: 1

9.HRP Stop Solution, 0.334M Sulfuric Acid, 1 vial – colorless, 10mL.

• 關聯藥證數量: 1

9.Nitrite：1.4% w/w ρ-arsanilic acid；1.3% w/w 1,2,3,4-tetrahydrobenzo(h)-quinolin-3-ol；10.8% w/w buffer；86.5% w/w nonreactive ingredients

• 關聯藥證數量: 1

9.P100-calibrator:A ready-to-use M.pneumoniae IgG high positive human serum. Contains 100BU/ml of IgG (arbitary binding units.)Contains less than 0.05% Proclin as a preservative. 96 Tests--1 vial, 0.75ml 192 Tests--1 vial, 1.25ml10.Concentrated HRP-Conjugate (300X):Horseradish peroxidase (HRP) conjugated anti-human IgG (gamma chain specific). Contains less than 0.05% Proclin as a preservative. 96 Tests--1 vial, 0.2ml 192 Tests-1 vial, 0.2ml11.TMB-Substrate:A ready-to-use solution. Contains 3,3',5,5'-tetramethylbenzidine as a chromogen and peroxide as a substrate. 96 Tests--1 Bottle, 14ml 1 Bottle 192 Tests--1 Bottle 24ml12.Stop Solution:A ready-to-use solution. Contains 1M H2SO4. 96 Tests--1 Bottle 15ml, 192 Tests--1 Bottle 30ml13.Plate Cover:96 Tests--1 Unit 192 Tests--2 Units

• 關聯藥證數量: 1

9.SUBSTRATE CONCENTRATE ONE BOTTLE CONTAINING 3,3'5,5'-TETRAMETHYLBENZIDINE (TMB) AND STABILISERS IN A PINK SOUTION.

• 關聯藥證數量: 1

9.Sample diluent. One 30 mL bottle (green cap) containing Tween-20, bovine serum albumin and phosphate-buffered-saline, (pH 7.2 ± 0.2). Green solution, ready to use. Preservative added. \n10.TMB: One 15 mL amber bottle (amber cap) containing 3,3’ ,5,5’ –tetramethylbenzidine (TMB). Ready to use. Contains DMSO < 15% (w).\n11.Stop solution: One 15 mL bottle (red cap) containing 1M H2SO4, 0.7M HCl. Ready to use.\n12.Wash buffer concentrate (10X): dilute 1 part concentrate + 9 parts deionized or distilled water. One 100 mL bottle (clear cap) containing a 10X concentrated phosphate-buffered-saline and Tween-20 solution (blue solution). Contains preservative NOTE: 1X solution will have a pH of 7.2 ± 0.2.

• 關聯藥證數量: 1

9.WASH FLUID: ONE BOTTLE CONTAINING 125 ML OF 20 TIMES WORKING STRENGTH GLYCINE/BORATE WASH FLUID. CONTAINS 0.2% BRONIDOX PRESERVATIVE.

• 關聯藥證數量: 1

9.WASH FLUID: ONE BOTTLE OR TWO BOTTLES CONTAINING 125ML OF 20 TIMES WORKING STRENGTH GLYCINE/BORATE WASH FLUID. CONTAINS 0.2 % BRONIDOX PRESERVATIVE.

• 關聯藥證數量: 1

90.0% to 105.0% of the peptide C145H240N44O48S2 (anhydrous and acetic acid-free substances). By convention, for the purpose of labeling Calcitonin (Salmon) preparation, 1 mg of Calcitonin (Salmon) (C145H240N44O48S2) is equivalent to6000 IU if biological activity.

• 關聯藥證數量: 1

9024661：Power cord,Hand sealer,Exchangeable cable,Transport Case.\n9024651：Power cord,Hand sealer,Exchangeable cable,Coaxial extension cable.\n9024401：Carrying bag,Hand sealer,Exchangeable cable,Charging Unit,Powerpack.

• 關聯藥證數量: 1

9152601TW：blood glucose monitor\n9152652TW：Omnitest plus (kit)\n9152709TW：2x25 test strips in filp top vials\n9152725TW：1x25 test strips in filp top vials\n9152750TW：control solution (1x3 ml bottle)\n9152806G：PC Interface Cable\n9152856G：USB Interface Cable

• 關聯藥證數量: 1

95%灑精加至

• 關聯藥證數量: 1

95.0% 102.0% Calculated on the anhydrous basis and contains potassium clavulanate (C8 H8KNO5)：96.5% to 102.0% (calculated on anhydrous basis). And the ratio of Amoxicillin to Clavulanic acid is 4：1.

• 關聯藥證數量: 1

95％酒精

• 關聯藥證數量: 1

96 Tests/Kit, 480 Tests/Kit1.HCV Antigens Plate：96wells × 1, 96wells × 5.2.Conc. Anti-Human-IgG？HRPO Conjugate：2ml × 1, 5ml × 13.Conjugate Diluent：20ml × 1, 100ml × 14.Anti-HCV Positive Control：0.5ml × 1, 3ml × 15.HC Negative Control：0.5ml × 1, 3ml × 16.Specimen Diluent C：30ml × 1, 100ml × 17.2N Sulfuric Acid：10ml × 1, 50ml × 18.Washing Solution D (20X) Concentrated ：100ml × 1, 400ml × 19.TMB Substrate Solution A：10ml × 1, 35ml × 110.TMB Substrate Solution B：10ml × 1, 35ml × 1

• 關聯藥證數量: 1

96-Well Primer Set Trays 3 tests/tray\nTray Seals\nD-mix Aliquots 360 ul/tube

• 關聯藥證數量: 1

98.0%~101.0% of mecobalamin (C63H91CoN13O14P), calculated on the anhydrous basis.

• 關聯藥證數量: 1

98.0%~102.0% of C21H25ClN2O3 • 2HCl, on the dried basis.

• 關聯藥證數量: 1

99.5% Alcohol

• 關聯藥證數量: 1

9K12-01/9K12-03 Abbott multi-Collect Specimen Collection Kit\n1.Transport Tube with Solid Cap containing 1.2 mL Specimen Transport Buffer (guanidine thiocyanate in Tris buffer)

• 關聯藥證數量: 1

<0.3% Potassium hydroxide.

• 關聯藥證數量: 1

<Ingredients related to reactions>\nBuffer solution：DTNB\nphosphate buffer solution\nSubstrate stock solution：Acetylcholine iodide\nSubstrate dilution solution\n<Concentration of the reaction solution>\nphosphate buffer sol：pH7.2(25℃)\nAcetylcholine iodide：5.4 mmol/L\nDTNB：0.28 mmol/L

• 關聯藥證數量: 1

?本

• 關聯藥證數量: 1

?甲

• 關聯藥證數量: 1

?白

• 關聯藥證數量: 1

A CONJ OF PRP(POLYRIBOSYL RIBITOL PO4) AND OMPC(OUTER M

• 關聯藥證數量: 1

A SOLUTION OF PROTEOLYTIC ENZYME

• 關聯藥證數量: 1

A combination of monoclonal and polyclonal antibodies.

• 關聯藥證數量: 1

A cridine orange, potassium oxalate, sodium heparin, dipotassium EDTA, agglutinating agent and stabilizers.

• 關聯藥證數量: 1

A liquid animal serum produced by immunization of rabbits with highly purified human a1-microglobulin.

• 關聯藥證數量: 1

A liquid preparation of stabilized human erythrocytes and leukocytes in a stabilizing solution containing BSA.

• 關聯藥證數量: 1

A lyophilized preparation of stabilized, buffered human plasma containing less than 5% bovine plasma.

• 關聯藥證數量: 1

A monoclonal antibody specific to hCG in a one-step lateral flow chromatographic immunoassay to accurately detect hCG at the level close to or greater than 25mIU/ml.

• 關聯藥證數量: 1

A phosphate buffered saline solution which contains glycine, EDTA, bovine albumin, gelatin and sodium azide in concentrations similar to that found in Immucor Monoclonal Blood Grouping Reagents and Gamma-Clone blood grouping reagents.

• 關聯藥證數量: 1

A pool of undiluted negative serum samples drawn from 5 to 10 non-transfused male blood donors.

• 關聯藥證數量: 1

A suspension of polystyrene particles in a buffered medium containing a surfactant.

• 關聯藥證數量: 1

A. Anti-Inhibin A-Coated Microtitration Strips:coated with anti-Inhibin βA subunit antibody immobilized to the inside wall of each well.B. Inhibin A Standard A/Sample Diluent:containing 0 pg/mL dimeric Inhibin A in fetal bovine serum with a non-mercury preservative.C. Inhibin A Standards:labeled B-G, containing concentrations of approximately 10, 30, 100, 250, 500, and 1000 pg/mL dimeric Inhibin A in fetal bovine serum with a non-mercury preservative.D. Inhibin A Controls:Levels I and II, containing low and high concentrations of Dimeric Inhibin A infetal bovine serum with a non-mercury preservative.E. Inhibin A Sample Buffer A:containing a protein-based buffer with a non-mercury preservative.F. Inhibin A Sample Buffer B: containing a protein-based buffer with a non-mercury preservative.G. Inhibin A Antibody-Enzyme Conjugate Concentrate:containing 0.6 mL of a solution of anti-Inhibin α-subunit antibody conjugate to horseradish peroxidase in a protein-based buffer with a non-mercury presercative

• 關聯藥證數量: 1

A. TSH Receptor Coated Wells\nB. Start buffer\nC. Calibrators\nD1. Negative control\nD2. Positive control\nE. M22-Peroxidase\nF. M22-Peroxidase reconstitution buffer\nG. Peroxidase substrate\nH. Concentrated wash buffer\nI. Stop solution\n

• 關聯藥證數量: 1

A. ACTH Standards: (Lyophilized) One vial, labeled A, containing 0 pg/mL and five vials, labeled B-F, containing concentrations of approximately 25, 100, 200, 500 and 1000 pg/mL (5.5 -220.0 pmol/L) ACTH in a protein-based buffer with sodium azide as a preservative. Refer to vial labels for exact concentrations. Store unopened at 2-8°C until expiration date. Reconstitute Standard A with 5 mL of ACTH Buffer. Reconstitute Standards B-F with 1 mL of ACTH Assay Buffer. Use immediately upon reconstitution. Discard after use. STANDARDIZATION NOTE: The ACTH Standards & Controls have been calibrated to the World Health Organization International Reference Reagent for ACTH (code 74/555) and performance verified by immunoassay. B. ACTH [I-125] Reagent: (Lyophilized) (RED) One vial, containing < 5 μCi (185 kBq) of [I-125]-labeled ACTH in a buffer with a protein stabilizer and sodium azide as a preservative. Store unopened at 2-8°C until expiration date. Reconstitute with 11 mL ACTH Assay Buffer. Use immediately upon reco

• 關聯藥證數量: 1

A. ACUTUS ANTIVENIN

• 關聯藥證數量: 1

A. ANTI-HUMAN LUTEINIZING HORMONE COATED TUBES B.LH STANDARDS C.ANTI-hLH 125│ D.ASSAY DILUENT E.WASH DILUENT

• 關聯藥證數量: 1

A. Androstenedione Standards: (Lyophilized)\n One vial, labeled A, containing 0 ng/mL. And rostenedione, and five vials, labeled B-F, containing concentrations of approximately 0.30,1.00,3.00 and 10.00 ng/mL (0.34-34.50 nmol/L) and rostenedione are buffer-based, with sodium azide as a preservative.\n *DSL-3800 (500 Tubes) contains three sets of standards\n B. Androstenedione [I-125] Reagent: (YELLOW)\n One bottle, 55 mL, containing <5 μCi (185 kBq) of [I-125]-labeled androstenedione in a protein-based buffer with sodium azide as preservative.\n *DSL-3800 (500 Tubes) contains five bottles of reagent.\n C. Anti-Androstenedione-Coated Tubes: (METALLIC GOLD)\n One hundred (100) plastic tubes each, with rabbit anti-androstenedione immunoglobulin immobilized to the inside wall of each tube.\n *DSL-3800 (500 Tubes) contains five hundred (500) tubes each.\n D. Androstenedione Controls: (Lyophilized)\n Two vials, Levels I and II, containing low high concentrations of androstenedione are buffer-based with sodium

• 關聯藥證數量: 1

A. Anti-IGF-1-Coated Microttitration Strips: One stripholder containing 96 microtitration wells coated with anti-IGF-1 antibody.\nB. IGF-1 Standard A/Sample Diluent: containing 0 ng/ml IGF-1 in protein-based (BSA) buffer with a non-mercury preservative.\nC. IGF-1 Standard B-F: containing concentrations of approximately 10, 50, 140, 300, and 600 ng/ml IGF-1 (synthetic) in a protein-based (BSA) buffer with a non-mercury preservative.\nD. IGF-1 Controls: containing low and high concentrations of IGF-1 in a protein-based (BSA) buffer with non-mercury preservative.\nE. Assay Buffer B: containing a protein-based (BSA) buffer with a non-mercury preservative.\nF. IGF-1 Antibody-Enzyme Conjugate Concentrate: containing anti-IGF-1 antibody conjugated to the enzyme horseradish peroxidase in a protein-based (BSA) buffer with a non-mercury preservative.\nG. TMB Chromogen Solution: containing a solution of tetramethylbenzidine (TMB) in buffer with hydrogen peroxide.\n

• 關聯藥證數量: 1

A. Anti-IGF-II-Coated Microttitration Strips: One stripholder containing 96 microtitration wells coated with anti-IGF-II antibody.\nB. IGF-II Standards: containing concentrations of approximately 0, 50, 150, 400, 800, 1500 and 2000 ng/ml IGF-II in protein-based buffer with sodium azide as a preservative.\nC. IGF-II Controls: containing low and high concentrations of IGF-II in a protein-based buffer with sodium azide as a preservative.\nD. IGF-II Assay Buffer: containing a protein-based buffer with a non-mercury preservative.\nE. IGF-II Antibody-Enzyme Conjugate Concentrate: containing anti-IGF-II antibody conjugated to the enzyme horseradish peroxidase in a protein-based buffer with a non-mercury preservative.\nF. TMB Chromogen Solution: containing a solution of tetramethylbenzidine (TMB) in buffer with hydrogen peroxide.\nG. Sample Buffer I: containing sample buffer with a non-mercury preservative.\nH. Sample Buffer II: containing sample buffer with a non-mercury preservative.

• 關聯藥證數量: 1

A. Anti-Prolactin coated tubes are coated with an antibody having a high affinity for human prolactin. B. Seven standards in a horse serum based matrix containing sodium azide and gentamicin sulfate are provided at the following concentrations: 0,2.5,5,10,25,50and 100 ng/mL. C. Wash diluent is a phosphate buffered saline diluent containing polyoxyethylene sorbitan monolaurate. D. Anti-Prolactin-125I is labeled with 125I and is specific against a different epitope of the Prolactin molecule than the antibody bound to the tube. It is provided in a phosphate-albumin diluent containing sodium azide as a preservative.

• 關聯藥證數量: 1

A. Calcitonin Standards: (Lyophilized)\nOne vial, labeled A, containing 0 pg/mL and five vials, labeled B-F, conaining concentrations of approximately 25, 100, 200, 500 and 1000 pg/mL (7.2-290.0) synthetic human calcitonin in buffer containing protein stabilizer and sodium azide as a preservative. \nB. Ca;citonin [I-125] Reagent: (Lyophilized) (YELLOW)\nOne vial, containing <5 μCi (185 kBq) of [i-125]-labeled human synthetic calctionin in a buffer with a protein stabilizer and sodium azide as a preservative.\nC. Calcitonin antiserum: (Lyophilized) (BLUE)\nOne vial, containing goat anti-human calcitonin serum in a buffer with a protein stabilizer and sodium azide as a preservative.\nD. Precipitating Reagent: (GREEN)\nOne bottle, 100 mL, containing donkey anti-goat gamma globulin, with polyethylene glycol as a precipitating did, and sodium azide as a preservative. \nE. Calcitonin Controls: (Lyophilized)\nTwo vials, levels i and II, containing low and high concentrations of calcitonin with sodium azides as a pre

• 關聯藥證數量: 1

A. Estradiol Standards:\nOne vial, 2.0 mL, labeled A, containing 0 pg/mL estradiol and six vials, 1 mL each, labeled B-G, containing concentrations of approximately 5, 10, 20, 50, 250 and 750 pg/mL (0.018-2.78 nmol/L) estradiol in serum. \nB. Estradiol [I-125] Reagent: (YELLOW)\nOne vial, 11 mL, containing < 5 μCi(185 kBq) of [I-125]-labeled estradiol in a protein-based (BSA) buffer. \nC. Estradiol Antiserum: (BLUE)\nOne vial, 11 mL, containing rabbit anti-estradiol (polyclonal) serum in a protein-based (BSA) buffer. \nD. Precipitating Reagent:\nOne bottle, 100 mL, containing goat anti-rabbit gamma globulin serum in a buffer with polyethylene glycol as a precipitating aid. \nE. Estradiol Controls:\nTwo vials, levels I and II, containing low and high concentrations of estradiol in serum.

• 關聯藥證數量: 1

A. GARG-Coated Microtitration Strips:\nOne stripholder, containing 96 polystyrene microtiter wells with goat anti-rabbit globulin serum\nB. Cortisol Antiserum: (Blue)\nOne vial, 11 mL, containing rabbit anti-cortisol serum in a protein-based (BSA) buffer with a non-mercury preservative.\nC. Cortisol Standards:\nOne vial, 0.5 mL, labeled A, containing 0 μg/dL cortisol and 7 vials, 0.5 mL each, labeled B-H, containing concentrations of approximately 0.5, 1.5, 4.0, 10.0, 20.0, 40.0, and 60.0 μg/dL cortisol in protein-based (BSA) buffer with a non-mercury preservative.\nD. Cortisol Controls:\nTwo vials, 0.5 mL each, Level I and II, containing low and high concentrations of cortisol in protein-based (BSA) buffer with a non-mercury preservative.\nE. Cortisol Enzyme Conjugate Concentrate:\nOne vial, containing 0.3 mL of a solution of cortisol conjugated to horseradish peroxidase in a protein-based (BSA) buffer with a non-mercury preservative.\n

• 關聯藥證數量: 1

A. IGF-I Standards: (Lyophilized)Six vials, labeled A-F, containing concentrations of approximately 0,8,30,100,300, and 1000 ng/mL (1.1-130 nmol/L) of IGF-I in a protein-based (BSA) buffer with a non-mercury preservative.B. Anti-IGF-I [I-125] Reagents: (RED)One bottle, 22 mL, containing < 10μCi (370kBq) of [I-125]-labeled anti-IGF-I in a protein –based (BSA) bufferC. Anti-IGF-I Coated Tubes: (METALLIC LIHGT GREEN RIM)One hundred (100) plastic tubes with Anti-IGF-I immunoglobulin immobilized to the inside wall of each tube.D. Sample Diluent:One bottle, 105 mL, containing sample buffer with sodium azide as a preservative.E. Wash Concentrate:One bottle, 60 mL, containing buffer with a non-ionic detergent.F. IGF-I Controls: (Lyophilized)Two vials, Level I and Level II, containing Low and high concentrations of IGF-I in a protein-based (BSA) buffer with non-mercury preservative.

• 關聯藥證數量: 1

A. Insulin Standards:\n One vial, labeled A, containing 0 μIU/mL and five vials, labeled B-F, containing concentrations of approximately 5, 15, 50, 150 and 300 μIU/mL (0.2-12 ng/mL) of insulin in a protein-based buffer with sodium azide as a preservative.\nB. Insulin I-125 Reagent: \n One vial, containing < 5 μCi (185 kBq) of I-125-labeled insulin in a protein-based buffer with sodium azide as a preservative.\nC. Insulin Antiserum: \n One vial, containing guinea-pig anti-insulin serum with sodium azide as a preservative.\nD. Precipitating Reagent:\n One bottle, 105 mL, containing goat anti-guinea pig gamma globulin serum with polyethylene glycol as a precipitating aid and sodium azide as a preservative.\nE. Insulin Controls:\n Two vials, Level I and II, containing a low and high level of insulin in a protein-based buffer with sodium azide as a preservative.\n\n

• 關聯藥證數量: 1

A. Reagent: Copper (II) acetate, potassium iodide, sodium hydroxide detergent.\nS. Protein Standard: Bovine albumin.

• 關聯藥證數量: 1

A. Renin Standards: Five vials, labeled A-E, containing approximate concentrations of 0, 5, 20, 100, and 500 pg/ml of Renin (Active form) in serum.\nB. Anti-Renin-Coated Beads: One bottle, containing 100 hundred beads coated with anti-human Renin antibody.\nC. Anti-Renin [I-125] Reagent: One vial, 11 ml, containing < 10 μCi (370 kBq) of [I-125]-labeled anti-human Renin antibody in a protein-stabilized (BSA) buffer.\nD. Renin Controls: Two vials containing low and high concentrations of human Renin in serum.\n\n

• 關聯藥證數量: 1

A.Reagent. Pipes 35 mmol/L, sodium cholate 0.5 mmol/L, phenol 28 mmo/L, cholesterol esterase-0.2 U/mL, cholesterol oxidase-0.1 U/mL, peroxidase-0.8 U/mL, 4-aminoantipyrine 0.5 mmol/L, pH 7.0.\nS.Cholesterol Standard.Cholesterol 200 mg/dL (5,18 mmol/L). Aqueous primary standard.

• 關聯藥證數量: 1

A.Reagent: Tris 150mmol/L, L-alanine 750mmol/L, lactate dehydrogenase>1350U/L, pH7.3.\nB.Reagent: NADH 1.3mmol/L, 2-oxoglutarate 75 mmol/L, Sodium hydroxide 148 mmol/L, sodium azide 9.5g/L.

• 關聯藥證數量: 1

A/California/7/2009(H1N1)

• 關聯藥證數量: 1

A/California/7/2009(H1N1)v-like virus

• 關聯藥證數量: 1

A/Darwin/9/2021 (H3N2) - like strain (A/Darwin/6/2021, IVR-227)

• 關聯藥證數量: 1

A/Guangdong-Maonan/SWL1536/2019 (H1N1) pdm09-like virus (A/Gunagdong-Maonan/SWL1536/2019 (CNIC-1909))

• 關聯藥證數量: 1

A/Hong Kong/2671/2019 (H3N2)-like virus (A/Hong Kong/2671/2019 (IVR-208))

• 關聯藥證數量: 1

A/Hong Kong/4801/2014 (H3N2)-like strain (A/Hong Kong/4801/2014, NYMC X-263B)

• 關聯藥證數量: 1

A/MOSCOW/10/99 (H3N2)-LIKE STRAIN

• 關聯藥證數量: 1

A/Massachusetts/18/2022 (H3N2)-like virus (A/Sydney/1304/2022)

• 關聯藥證數量: 1

A/Michigan/45/2015 (H1N1) pdm09 - like strain (A/Michigan/45/2015, NYMC X-275)

• 關聯藥證數量: 1

A/Michigan/45/2015 (H1N1)pdm09 - like strain (A/Singapore/GP1908/2015, IVR-180)

• 關聯藥證數量: 1

A/NEW CALEDONIA/20/99 (H1N1)-LIKE STRAIN

• 關聯藥證數量: 1

A/Norway/31694/2022 (H1N1, A/Victoria/4897/2022-like)

• 關聯藥證數量: 1

A/Perth/722/2024 (H3N2) (A/Croatia/10136RV/2023-like virus)

• 關聯藥證數量: 1

A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus (A/Singapore/INFIMH-16-0019/2016 , Reassortant IVR-186)

• 關聯藥證數量: 1

A/Strain H1N1

• 關聯藥證數量: 1

A/Strain H3N2

• 關聯藥證數量: 1

A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022)

• 關聯藥證數量: 1

A/Thailand/8/2022 (H3N2)-like virus A/California/122/2022 (SAN-022)

• 關聯藥證數量: 1

A/Victoria/2570/2019 (H1N1)

• 關聯藥證數量: 1

A/Victoria/361/2011(H3N2)

• 關聯藥證數量: 1

A/WISCONSIN/67/2022 (H1N1) PDM09 - LIKE VIRUS (A/GEORGIA/12/2022 CVR-167)

• 關聯藥證數量: 1

A07-170 Regan Lowe Transtube：Charcoal Agar ,Dist. Water, Cephalexin Hydra,Sheep Blood .\nA07-1861 Cary Blair Swab：Na2HPO4？12H2O,Dist. Water,NaCl ,Sodium Thioglycolate, Agar, \nCaCl2？2H2O.\nA07-185 Cary Blair Stool Cup：Na2HPO4？12H2O,Dist. Water,NaCl,Sodium Thioglycolate,Agar,CaCl2？2H2O,Egg Yolk.\nA07-186 Cary Blair Transport：Na2HPO4？12H2O ,Dist. Water,NaCl,Sodium Thioglycolate,Agar,CaCl2？2H2O.\nA07-169 Campy Transtube：Agar ,NaCl ,KCl,Thioglyolic acid,Na2HPO4？12H2O,KH2PO4,MgCl2？6H2O,CaCl2？2H2O,Dist. Water,Egg Yolk.

• 關聯藥證數量: 1

A1 M Antibody...................5MLAGXS4..............................5MLSODIUM AZIDE<0.1% (W/W)

• 關聯藥證數量: 1

A201: a lyophilized preparation of acetone dried rabbit brain thromboplastin, stabilizers and buffers.\nPT: 45 pouches, each containing one HEMOCHRON Jr. PT test cuvette.

• 關聯藥證數量: 1

A301: contains a lyophilized preparation of human thrombin, calcium salts, stabilizers and buffers.\nA501: contains a lyophilized preparation of human thrombin, snake venom, protamine sulfate, calcium salts, stabilizers and buffers.\n

• 關聯藥證數量: 1

A: Reconstituting Solution\nB: Sample Diluent\nC: Sensitized Particles\n Lyophilized preparation of gelatin particles sensitized with streptolysin-O.\nD: Control Particles\n Lyophilized preparation of gelatin particles sensitized with bovine serum albumin.\nE: Positive Control

• 關聯藥證數量: 1

AAG 試劑筒 AAG抗體.....3.9Ml 防蒸發蓋....................2 AAG試劑條碼卡.........1 疊氮化鈉<0.1% (重量/重量)

• 關聯藥證數量: 1

AAT 抗体卡 1 AAT 抗体 (處理過的羊血清) 5mL ?氮鈉 (用作防腐劑) <0.1% (w/w)

• 關聯藥證數量: 1

ABBOTT ARCHITECT Cortisol Calibrators\n6 Bottles (4.0 mL each) of ARCHITECT Cortisol Calirators. The calibrators yield the following concentrations：\nCAL A 0 μg/dL, 0 nmol/L；CAL B 3.0 μg/dL, 82.8 nmol/L；CAL C 5.4 μg/dL, 149.0 nmol/L；CAL D 10.7 μg/dL, 295.2 nmol/L；CAL E 25.2 μg/dL, 695.3 nmol/L；CAL F 59.8 μg/dL, 1649.9 nmol/L

• 關聯藥證數量: 1

ABBOTT ARCHITECT Cortisol Reagent Kit (100 Tests/500 Tests)\nMicroparticles：1 Bottle (6.6 mL/27.0 mL) Anti-cortisol coated microparticles in TRIS/BIS-TRIS buffer with protein stabilizer.\nConjugate：1 Bottle (5.9 mL/26.3 mL) Cortisol acridinium-labeled conjugate in citrate buffer with surfactant stabilizer.

• 關聯藥證數量: 1

ABBOTT ARCHITECT iDigoxin Reagent Kit (100 Tests):\nMicroparticles 1 Bottle (6.6 mL) Anti-digoxin coated microparticles in TRIS buffer with protein stabilizer.\nConjugate 1 Bottle (5.9 mL) Digoxigenin acridinium-labeled conjugate in citrate buffer.\nAssay Diluend 1 Bottle (10.0 mL) Assay Diluent containing goat serum with EDTA disodium.\nABBOTT ARCHITECT iDigoxin Calibrators\n6 Bottles (4.0 mL each) of ARCHITECT iDigoxin Calibrators.

• 關聯藥證數量: 1

ABBOTT ARCHITECT iPhenobarbital Calibrators\n6 Bottles (4 mL each) of ARCHITECT iPhenobarbital Calibrators. The calibrators yield the following concentrations：0.0, 5.0, 10.0, 20.0, 40.0, 80.0 mg/L.

• 關聯藥證數量: 1

ABBOTT ARCHITECT iPhenobarbital Reagent Kit (100 Tests)\nMicroparticles：1 Bottle (6.6 mL) Anti-phenobarbital coated goat anti-mouse microparticles in TRIS buffer with protein stabilizer.\nConjugate：1 Bottle (5.9 mL) Phenobarbital acridinium-labeled conjugate in MES buffer with surfactant.

• 關聯藥證數量: 1

ABBOTT ARCHITECT iPhenytoin Calibrators\n6 Bottles (4 mL each) of ARCHITECT iPhenytoin Calibrators. The calibrators yield the following concentrations：\nCAL A 0.0 (μg/mL) or (mg/L), 0.0 (μmol/L)；CAL B 2.5 (μg/mL) or (mg/L), 9.9 (μmol/L)；CAL C 5.0 (μg/mL) or (mg/L), 19.8 (μmol/L)；CAL D 10.0 (μg/mL) or (mg/L), 39.6 (μmol/L)；CAL E 20.0 (μg/mL) or (mg/L), 79.2(μmol/L)；CAL F 40.0 (μg/mL) or (mg/L), 158.4 (μmol/L)

• 關聯藥證數量: 1

ABBOTT ARCHITECT iPhenytoin Reagent Kit (100 Tests)\nMicroparticles：1 Bottle (6.6 mL) Anti-Phenytoin coated goat anti-mouse microparticles in MES buffer with protein stabilizer.\nConjugate：1 Bottle (5.9 mL) Phenytoin acridinium-labeled conjugate in MES buffer with surfactant.

• 關聯藥證數量: 1

ABBOTT Clinical Chemistry ICT Urine CalibratorCONTENTSICT Urine Calibrator is prepared in a aqueous solution.Analyte Concentration Units URINE CAL L URINE CAL HSodium 50 180 mmol/LPotassium 9.0 90 mmol/LChloride 50 180 mmol/L

• 關聯藥證數量: 1

ABBOTT PRISM HIV O Plus Assay Kit1. 1 bottle (324ml) HIV-1/HIV-2 (E.coli, B. megaterium, recombinant) Antigen Coated Microparticles in phosphate buffer with CHAPS and Protein stabilizers.2. 1 bottle (331ml) Anti-Biotin (mouse monoclonal): Acridinium Conjugate in phosphate buffered saline, with Triton X-100 and Protein stabilizers. Minimum concentration:0.025u g/ml.3. 3 bottle (10.4ml each) Negative Calibrator (Human). Recalcified plasma nonreactive for HBsAg, HIV-1 Ag, Anti-HCV and anti-HIV-1/HIV-2。4. 3 bottle (10.4ml each) HIV-1 Positive Calibrator (Huamn) Recalcified, heat-inactivated plasma reactive for anti-HIV-1, Nonreactive for HBsAg and anti-HCV.5. 1 bottle (16ml) Probe 20x Concentrate: Biotinylated HIV-1/HIV-2 (E. coli, Recombinant) antigen and synthetic peptide in borate buffer with protein stabilizers.6. 3 bottle (10.4ml each) HIV-2 Positive Assay Control (Human) Recalcified, heat-inactivated plasma reactive for anti-HIV-2, Nonreactive for HBsAg and anti-HCV.7. 1

• 關聯藥證數量: 1

ABCIXIMAB (C7E3 FAB)

• 關聯藥證數量: 1

ABSINTHIUM

• 關聯藥證數量: 1